HEMA: Acquired by Charles River Laboratories International, Inc. (CRL). Each outstanding share of common stock will be canceled and converted solely into the right to receive $25.40 in cash.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.